Boost your SEO with Backlinks that are worth it

Turn scattered startup information into focused action.

Submit your startup to 120+ top directories.

Edit

Upgrade

Rigontec GmbH

Rigontec is the leader in RIG-I targeting RNA therapeutics developing novel immuno-oncology treatment options

Acquired by Merck & Co., Inc. on September 06, 2017

Website: https://rigontec.com

Founded: January 01, 2014

Social:

Add Competitor

Startup	Industry	Description
Medikal	-	Medikal.com is a global professional networking platform for the healthcare industry. - Medikal - A professional social network for making ...
Chemists World	Healthcare Equipment & Services	Online Medical Store in India - Chemists World is one of the best online pharmacie ...
Lighthouse Recovery Texas	Healthcare Equipment & Services	Addiction treatment in Dallas, TX - Lighthouse Recovery Texas is a premier addiction t ...

View more competitors»

Date	Round	Amount	Investors
Sep 06, 2016	Series A	€ 15,000,000	High Tech Gruenderfonds MP Healthcare Venture Management Wellington Partners NRW.BANK Sunstone Capital Boehringer Ingelheim Venture Fund Forbion Capital Partners
Mar 24, 2015	Series A	€ 4,800,000	Forbion Capital Partners Sunstone Capital NRW.BANK Wellington Partners Boehringer Ingelheim Venture Fund
Oct 14, 2014	Series A	€ 9,450,000	Wellington Partners NRW.BANK High Tech Gruenderfonds Boehringer Ingelheim Venture Fund

Date	Acquired	Amount
There are no acquisitions.

Product	Stage	Description
There are no products.